A targeted antibody‑drug conjugate shrinks tumors and slows progression in recurrent uterine cancer by ferrying potent ...

A targeted treatment that triggers the death of cancer cells has shown promise for patients with advanced bowel cancer when ...

Adults with mantle cell lymphoma who have already failed two or more treatments, including a BTK inhibitor, now have a new ...

A new study co-led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center shows that the targeted cancer ...

Oliver Farry is pleased to welcome Dr. Thomas Pudlarz, Medical Oncologist and Head of the pancreatic care pathway within the ...

A major real-world study by University of California, Irvine pharmacy researchers has found serious blood-related side ...

Adding encorafenib and cetuximab to chemotherapy backbone also prolonged overall survival ...

The targeted therapy sunvozertinib was more effective than standard platinum-based chemotherapy as a first-line treatment for ...

Dedifferentiated liposarcoma (DDLS) is a rare and aggressive soft tissue cancer with few effective treatment options. But now ...

Targeted therapies are medicines to treat cancer. They work differently than standard chemotherapy. Instead of killing all fast-growing cells or keeping them from dividing, targeted therapies work ...

Keaton Herzer tells PEOPLE a newer targeted therapy unexpectedly shrank his tumors enough to qualify for a liver transplant ...

Targeted therapies are cancer medications that work more selectively than standard chemotherapy medications. They do this by targeting specific molecules or genetic changes in cancer cells in order to ...